BlackRock
BMEBlackRock Health Sciences Trust Price (BME)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
13,943,973
(0)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
BlackRock Health Sciences TrustCurrency: USD
| YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
0.00
+0% |
-25,970,949.00
+0% |
20,410,615.00
-179% |
24,071,879.00
+18% |
|||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -8,464,140.00 | 0.00 | |||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
0.00
+0% |
0.00
+0% |
-25,970,949.00
+0% |
28,874,755.00
-211% |
24,071,879.00
-17% |
|||||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.00%) | (1.00%) | (1.41%) | (1.00%) | |||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| General and Administrative | 0.00 | 0.00 | 0.00 | 362,164.00 | 299,026.00 | 355,526.00 | |||||||||||||
| Selling, General & Admin... | 0.00 | 0.00 | 0.00 | 362,164.00 | 299,026.00 | 355,526.00 | |||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Depreciation and Amortiz... | 171,860.00 | 206,297.00 | 236,558.00 | 228,485.00 | 11,560,458.00 | 0.00 | |||||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | -26,333,113.00 | 20,111,589.00 | 23,716,353.00 | |||||||||||||
| Total Operating Expenses | 0.00 | 0.00 | 0.00 | -25,970,949.00 | 20,410,615.00 | 24,071,879.00 | |||||||||||||
| Cost and Exponses | 0.00 | 0.00 | 0.00 | -25,970,949.00 | 20,410,615.00 | 24,071,879.00 | |||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
8,464,140.00
+0% |
-46,909,730.00
-654% |
|||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.41%) | (-1.95%) | |||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Interest Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 55.00 | 78.00 | |||||||||||||
| Total Other Income/Exp... | 0.00 | 0.00 | 0.00 | -26,471,079.00 | 11,552,878.00 | 70,364,517.00 | |||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 20,024,598.00 | 0.00 | |||||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.98%) | (0.00%) | |||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 0.00 | 0.00 | 0.00 | -26,471,079.00 | 20,017,018.00 | 23,454,787.00 | |||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.00%) | (1.02%) | (0.98%) | (0.97%) | |||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 0.00
+0% |
0.00
+0% |
0.00
+0% |
-26,471,079.00
+0% |
20,017,018.00
-176% |
23,454,787.00
+17% |
|||||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (0.00%) | (1.02%) | (0.98%) | (0.97%) | |||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 1.45 | 11.63 | -2.55 | -2.10 | 1.44 | 1.68 | |||||||||||||
| Diluted EPS | 1.45 | 11.63 | -2.55 | -2.10 | 1.44 | 1.68 | |||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 78,089,172.00 | 112,695,132.00 | 112,880,936.00 | 12,605,276.00 | 13,943,973.00 | 13,943,973.00 | |||||||||||||
| Diluted Share Outstanding | 78,089,172.00 | 112,695,132.00 | 112,880,936.00 | 12,605,276.00 | 13,943,973.00 | 13,943,973.00 | |||||||||||||